159 related articles for article (PubMed ID: 18317795)
1. Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients.
Tauceri F; Mura G; Roseano M; Framarini M; Ridolfi L; Verdecchia GM
Langenbecks Arch Surg; 2009 Nov; 394(6):1079-84. PubMed ID: 18317795
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
Yuan GW; Li XG; Li N; Yao HW; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
[No Abstract] [Full Text] [Related]
3. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
7. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
9. Metastatic melanoma: Surgical treatment of brain metastases - Analysis of 110 patients.
McHugh FA; Kow CY; Falkov A; Heppner P; Law A; Bok A; Schweder P
J Clin Neurosci; 2020 Mar; 73():144-149. PubMed ID: 31956087
[TBL] [Abstract][Full Text] [Related]
10. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant therapies following surgery for anal melanoma.
Wong DL; Glazer ES; Tsao M; Deneve JL; Fleming MD; Shibata D
Am J Surg; 2022 Jun; 223(6):1132-1143. PubMed ID: 34801225
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430.
Sosman JA; Moon J; Tuthill RJ; Warneke JA; Vetto JT; Redman BG; Liu PY; Unger JM; Flaherty LE; Sondak VK
Cancer; 2011 Oct; 117(20):4740-06. PubMed ID: 21455999
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Jansen Y; Kruse V; Corthals J; Schats K; van Dam PJ; Seremet T; Heirman C; Brochez L; Kockx M; Thielemans K; Neyns B
Cancer Immunol Immunother; 2020 Dec; 69(12):2589-2598. PubMed ID: 32591862
[TBL] [Abstract][Full Text] [Related]
15. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
[TBL] [Abstract][Full Text] [Related]
17. Satellite and In-Transit Metastatic Disease in Melanoma Skin Cancer: A Retrospective Review of Disease Presentation, Treatment, and Outcomes.
Bann DV; Chaikhoutdinov I; Zhu J; Andrews G
Dermatol Surg; 2019 Mar; 45(3):371-380. PubMed ID: 30681423
[TBL] [Abstract][Full Text] [Related]
18. Stage-IV melanoma and pulmonary metastases: factors predictive of survival.
Neuman HB; Patel A; Hanlon C; Wolchok JD; Houghton AN; Coit DG
Ann Surg Oncol; 2007 Oct; 14(10):2847-53. PubMed ID: 17680317
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.
Ridolfi L; Ridolfi R; Riccobon A; De Paola F; Petrini M; Stefanelli M; Flamini E; Ravaioli A; Verdecchia GM; Trevisan G; Amadori D
J Immunother; 2003; 26(2):156-62. PubMed ID: 12616107
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Morton DL; Hsueh EC; Essner R; Foshag LJ; O'Day SJ; Bilchik A; Gupta RK; Hoon DS; Ravindranath M; Nizze JA; Gammon G; Wanek LA; Wang HJ; Elashoff RM
Ann Surg; 2002 Oct; 236(4):438-48; discussion 448-9. PubMed ID: 12368672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
